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INTRODUCTION
Small interfering RNA (siRNA) represses
a specific target gene that has a perfectly
complementary sequence by a pathway
referred to as RNA interference (RNAi).
Researchers have successfully diverted this
natural pathway to artificially knockdown
intended genes. RNAi shows promise for
therapeutic applications to human dis-
eases (Castanotto and Rossi, 2009; Ketting,
2011). Over the past decade, more than
twenty siRNAs have been applied to clin-
ical trials for dozens of diseases, includ-
ing various cancers, viral infections, and
genetic disorders (Davidson and McCray,
2011; Snead and Rossi, 2012). Ongoing
patient trials are expected to yield suc-
cess. However, several major problems,
such as the efficacy and off-target effect
of siRNA, remain to be overcome before
RNAi-based therapeutics can be efficiently
introduced into clinical practice. In the
present paper, I propose a procedure for
selecting sequences of highly functional
siRNAs with few off-target effects.
FUNCTIONAL siRNAs
In RNAi experiments, siRNAs composed
of duplexes of 21-nucleotide (nt) RNA
with 2-nt 3′-overhangs are usually used.
As shown in Figure 1, siRNAs that are
incorporated into cells are transferred
to an RNAi effector complex called the
RNA-induced silencing complex (RISC)
(Hutvagner and Simard, 2008; Jinek
and Doudna, 2009), which contains the
Argonaute 2 (Ago2) protein with slicer
activity (Hammond et al., 2001; Martinez
et al., 2002). In the RISC, the siRNA duplex
is unwound into single-stranded RNAs.
The guide strand selectively retained on
the RISC base-pairs with the target mRNA.
Then, the target mRNA is silenced by
cleavage by Ago2 protein at the region
corresponding to the nucleotide posi-
tions 10–11 of the siRNA guide strand
(Elbashir et al., 2001; Hammond et al.,
2001; Martinez et al., 2002).
However, the efficacy of RNAi in mam-
malian cells varies considerably depending
on the siRNA sequence, and a limited pro-
portion of siRNAs is functional (Holen
et al., 2002; Harborth et al., 2003). We
and others have reported that preferable
incorporation of the siRNA guide strand
into the RISC is due to the asymmet-
rical features of both siRNA terminals
(Amarzguioui and Prydz, 2004; Reynolds
et al., 2004; Ui-Tei et al., 2004). The siRNA
guide strand, which has a thermodynam-
ically less stable 5′-end, is preferentially
retained on the RISC (Khvorova et al.,
2003; Schwarz et al., 2003; Ui-Tei et al.,
2004). In contrast, the passenger strand
is cleaved by the Ago2 protein on the
RISC and degraded (Matranga et al., 2005;
Miyoshi et al., 2005; Rand et al., 2005;
Leuschner et al., 2006). We extensively
examined the relationship between siRNA
sequence and its ability to give rise to
RNAi in mammalian cells (Ui-Tei et al.,
2004), and empirically defined the prac-
tical characteristics of highly functional
siRNAs as follows: (1) A or U residues at
nucleotide position 1; (2) four to seven
A/Us at nucleotide positions 1–7; and (3)
G/C at position 19, with the nucleotide
position measured from the 5′-end of the
guide strand (Figure 1). In addition, (4) a
GC stretch of no more than 9 nucleotides
should occur in the siRNA sequence.
Among these rules, Reynolds et al. (2004)
also showed that A is preferable at posi-
tion 1 and not G/C, and Amarzguioui
and Prydz (2004) also recommended A/U
but not G at this position. Furthermore,
Amarzguioui and Prydz also recommend
G/C but not U at the position 19.
All three features from (1) to (3) may be
involved in the thermodynamic asymme-
try of both terminals in the selection of the
functional guide strand RNA. However,
feature (1) should also be involved in the
other property that strongly contributes to
the RNAi activity. The 5′-end of the siRNA
guide strand is reported to be anchored
in the binding pocket of the Mid domain
of the Archaeoglobus fulgidus Ago-like pro-
tein (Ma et al., 2005; Parker et al., 2005).
The crystal structure of a MID domain of
human Ago2 and NMR titration experi-
ments showed that nucleotide monophos-
phates, AMP and UMP, bind with up to
30-fold higher affinities than either CMP
or GMP, providing structural evidence
for preferential interactions of the A/U
residues in the MID domain of eukary-
otic Ago proteins (Frank et al., 2010). In
the RNAi pathway, thermodynamic asym-
metry due to features (2) and (3) may be
essential for dissociating double-stranded
siRNA into single-stranded guide RNA
from its 5′-terminal. Then, the 5′-end
of the siRNA guide strand should be
anchored in the Ago2 pocket due to fea-
ture (1), immediately after unwinding,
since the passenger strand in the siRNA
duplex is cleaved by the catalytic activity
of Ago2 protein and degraded (Figure 1)
(Kawamata et al., 2009; Yoda et al., 2010).
However, in the case of siRNA with long
GC stretches, the 10-nt and 11-nt frag-
ments of the passenger strand cleaved by
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FIGURE 1 | Functional siRNA sequence and the mechanism of RNAi
without off-target effects in mammalian cells. An RNA strand with A or
U at position 1 measured from the guide strand 5′ end (1), four to seven
A/Us in positions 1–7 (2) and G/C at position 19 (3) are easily unwound
from the 5′ end and retained in the RISC. The passenger strand is cleaved
in the Ago2-containing RISC, but dissociated from the Ago1, 3, or
4-containing RISC following unwinding. In the RNAi pathway (left column),
the guide strand recognizes target mRNA with completely complementary
sequences, and the target mRNA is cleaved by the Ago2 protein.
However, off-target transcripts with partial complementary sequences to
the seed region positions 2–8 are downregulated or not downregulated
according to the thermodynamic stability of the duplex formed between
the siRNA seed region and target mRNA. The siRNAs with weak
seed-target base-pairing are not reduced by the off-target effect (middle
column), but those with strong base-pairing are downregulated by the
off-target effect (right column).
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Ago2 cannot be dissociated from the guide
strand due to the strong base-pairing by
the long GC stretch. This may explain why





RNAi has been assumed to be an extremely
specific procedure to knockdown a par-
ticular target gene. However, accumulated
evidence from genome-wide experiments
has revealed that numerous non-targeted
mRNAs with partially complementary
sequences in their 3′-UTRs to the guide
strand seed region (positions 2–8) are also
reduced (Jackson et al., 2003, 2006; Lin
et al., 2005; Birmingham et al., 2006; Ui-
Tei et al., 2008) through a mechanism
similar to that of miRNA silencing (Lewis
et al., 2005; Lim et al., 2005; Grimson
et al., 2007). This phenomenon is referred
to as the off-target effect, and it is likely to
be due to the fact that the seed region is
situated on the surface of Ago in a quasi-
helical form, serving as the entry or nucle-
ation site for small RNAs in the RISCs
(Ma et al., 2005; Yuan et al., 2005). In the
pathway of the off-target effect, most of
the siRNA duplexes may be loaded onto
Ago proteins other than Ago2, such as
Ago1, 3, and 4, which lack slicer activi-
ties (Figure 1). Thus, the thermodynamic
asymmetry of both terminals due to fea-
tures (1)–(3) should be essential for siRNA
unwinding, as the passenger strand in the
siRNA duplex is not cleaved by Ago2 pro-
tein, in contrast to the case of RNAi.
The off-target effect is induced by only
7-nt base-pairing between the siRNA seed
region and the mRNA 3′-UTRs. If such
7-nt base-pairing is a unique factor to
induce the off-target effect, a target gene-
specific RNAi is not possible, since ran-
dom 7-mer sequences are stochastically
distributed at about ≥1000 sites in 3′-
UTR regions. Comparing the efficien-
cies of off-target effects using various
reporter plasmids with different 7-nt seed
sequences, we found that the ability to
induce the off-target effect strongly corre-
lated with the thermodynamic stability of
the duplex formed between the siRNA seed
region and target mRNAs (Ui-Tei et al.,
2008, 2012). This result was confirmed by
genome-wide expression profiling using
siRNA with high or low seed-target sta-
bility (Ui-Tei et al., 2008). It was revealed
that siRNA with high stability (benchmark
melting temperature [Tm] ≥ 21.5◦C) in
the 7-bp duplex is a good inducer of
off-target activity, whereas siRNA with
low stability in the 7-bp duplex (Tm ≤
21.5◦C) is a poor inducer. Approximately
22% of the 16,384 sequences of 7-nt had
Tm-values ≤ 21◦C, indicating that limited
seed sequences are available for selecting
siRNAs with reduced off-target effects.
It was shown that siRNA off-target
effect is induced by a similar mechanism
to miRNA-mediated gene silencing (Lewis
et al., 2005; Lim et al., 2005; Grimson et al.,
2007). Thus, it was expected that miRNA
silencing efficacy is also determined by
the thermodynamic stability in the duplex
formed between the miRNA seed region
and the target mRNA. We carried out
reporter experiments using various miR-
NAs to evaluate their silencing effica-
cies. However, unlike the siRNA off-target
effect, the silencing efficacy of miRNA was
not simply determined by seed-target sta-
bility, but also affected by the instability
of the 5′ region of the miRNA duplex
(Hibio et al., 2012). MiRNAs with an
unstable 5′ terminal duplex and stable
seed-target duplex exhibit strong silenc-
ing activity. The RNA strand in a small
RNA duplex containing the thermody-
namically less stable 5′-end is preferen-
tially loaded onto the RISC (Khvorova
et al., 2003; Schwarz et al., 2003; Ui-Tei
et al., 2004). Although siRNA is sim-
ply composed simply of perfectly comple-
mentary double-stranded RNA, miRNA
has specific structural features, such as
an internal bulge/mismatch. Because the
5′ region and seed region overlap each
other, the stabilities of these regions
in siRNA are similar. These regions in
siRNA may function in a similar man-
ner, and the stability of seed region alone
is enough to define the efficacy of siRNA
off-target effect. However, the efficacy of
miRNA-mediated silencing activity may
be defined by the combination of the
nucleotide sequence in the seed region
and structure of 5′ region of miRNA
duplex. Although the structure depends
directly on the nucleotide sequence, the
sequence and the structure may contribute
to silencing efficacy as distinguishable
parameters.
CONCLUSION AND OPTIMAL CHOICE
OF FUNCTIONAL siRNAWITH
REDUCED OFF-TARGET EFFECT
For safe RNAi therapeutics, it is impor-
tant to select highly functional siRNAs that
have reduced off-target effects. I propose
that those siRNAs that simultaneously sat-
isfy the following five conditions should be
good candidates:
(1) A or U residues at nucleotide posi-
tion 1measured from the 5′-end of the
guide strand
(2) Four to seven A/Us in nucleotide posi-
tions 1–7 (A/U ≥ 57%)
(3) G/C at position 19
(4) No long GC stretch (≤9GC)
(5) Low thermodynamic stability in the
duplex formed between the siRNA
7-nt seed region and the target mRNA
(Tm ≤ 21.5◦C)
To facilitate the selection of such siRNAs,
we constructed the siRNA design web-
server siDirect 2.0 (http://siDirect2.RNAi.
jp/) (Naito et al., 2009; Naito and Ui-Tei,
2012). siRNAs for>94% of humanmRNA
sequences in RefSeq can be successfully
designed using our procedure.
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